The estimated Net Worth of Anthony R. Raab is at least $431 mil dollars as of 25 May 2021. Mr. Raab owns over 136,538 units of Senseonics Inc stock worth over $85,485 and over the last 4 years he sold SENS stock worth over $345,441. In addition, he makes $0 as Director at Senseonics Inc.
Anthony has made over 1 trades of the Senseonics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 136,538 units of SENS stock worth $345,441 on 25 May 2021.
The largest trade he's ever made was selling 136,538 units of Senseonics Inc stock on 25 May 2021 worth over $345,441. On average, Anthony trades about 27,308 units every 0 days since 2020. As of 25 May 2021 he still owns at least 217,022 units of Senseonics Inc stock.
You can see the complete history of Mr. Raab stock trades at the bottom of the page.
Anthony Raab serves as Director of the Company. He is a co-founder of Masters Special Situations, LLC (“Masters”), and has served as a Senior Analyst at Masters Capital Management since 2015. He received his B.A. in economics with a certificate in markets and management from Duke University in 2003.
Anthony Raab is 40, he's been the Director of Senseonics Inc since 2020. There are 16 older and no younger executives at Senseonics Inc. The oldest executive at Senseonics Holdings Inc is Dr. Francine Ratner Kaufman M.D., 70, who is the Chief Medical Officer & Director.
Anthony's mailing address filed with the SEC is C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876.
Over the last 9 years, insiders at Senseonics Inc have traded over $36,720,504 worth of Senseonics Inc stock and bought 30,963,337 units worth $56,759,340 . The most active insiders traders include Peter J Barris, M James Barrett, eDouglas A Roeder. On average, Senseonics Inc executives and independent directors trade stock every 45 days with the average trade being worth of $313,683. The most recent stock trade was executed by Sharon Larkin on 7 September 2023, trading 30,889 units of SENS stock currently worth $18,842.
senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm") system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
Senseonics Inc executives and other stock owners filed with the SEC include: